Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 4Myelodysplastic Syndromes 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Biphenotypic, Acute 1Graft vs Host Disease 1Ganglioneuroblastoma 1

Interventions

Specimen Handling 6fludarabine 5Whole-Body Irradiation 5Cytarabine 5Cyclophosphamide 5venetoclax 4Methotrexate 4Biopsy 4merphos 3fludarabine phosphate 3blinatumomab 3N,N-dicyclohexyl-isoborneol-10-sulfonamide 3Idarubicin 3Granulocyte Colony-Stimulating Factor 3prednylidene 2deltacortene 2calaspargase pegol 2Thiotepa 2Tacrolimus 2Stem Cell Transplantation 2Spinal Puncture 2Rituximab 2Prednisone 2Mycophenolic Acid 2Magnetic Resonance Spectroscopy 2Leucovorin 2Filgrastim 2CT-P10 2Busulfan 2Asparaginase 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Biphenotypic, Acute × Hematopoietic Stem Cell Transplantation × 30 days × Clear all
NCT06928662 2026-05-15

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
36 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡